Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Sacituzumab govitecan & Breast Cancer / Mammacarcinoma (TNBC), Sacituzumab govitecan, an Antibody-Drug-Conjugate (ADCs), is approved by both the FDA and the EMA for the treatment of Breast Cancer / Mammacarcinoma (TNBC), including metastatic forms (mTNBC) (1, 2, 3).
Progression-free and overall survival were significantly longer with sacituzumab govitecan than with single-agent chemot…